Canada - English - Health Canada

mylan pharmaceuticals ulc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Canada - English - Health Canada

sandoz canada incorporated - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - ranitidine -

United States - English - NLM (National Library of Medicine)

teligent pharma, inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - zantac injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable duodenal ulcers, or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication. zantac injection is contraindicated for patients known to have hypersensitivity to the drug.

United States - English - NLM (National Library of Medicine)

teligent, inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 25 mg in 1 ml - zantac injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable duodenal ulcers, or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication. zantac injection is contraindicated for patients known to have hypersensitivity to the drug.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ranitidine hydrochloride 28 mg/ml equivalent to ranitidine 25 mg/ml;   - solution for injection - 50mg/2ml - active: ranitidine hydrochloride 28 mg/ml equivalent to ranitidine 25 mg/ml   excipient: dibasic sodium phosphate monobasic potassium phosphate sodium chloride water for injection - zantac injection is indicated for the short-term treatment of duodenal ulcer, benign gastric ulcer, post-operative ulcer, reflux oesophagitis, zollinger-ellison syndrome, and the following conditions where a reduction of gastric secretion and acid output is desirable: the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson's) syndrome, particularly obstetric patients during labour.

Malta - English - Medicines Authority

glaxo wellcome uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ranitidine - syrup - ranitidine 150 mg - drugs for acid related disorders

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - syrup - ranitidine as hydrochloride 150 mg / 10 ml - ranitidine - ranitidine - adults:zantac syrup is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. zantac syrup is also indicated for the treatment of post-operative ulcer, zollinger-ellison syndrome and oesophageal reflux disease including long term management of healed oesophagitis. zantac syrup is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson's syndrome), particularly obstetric patients during labour. children (3 to 18 years):short term treatment of peptic ulcer. treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.

United States - English - NLM (National Library of Medicine)

doh central pharmacy - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir 200 mg - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. the following points should be considered when initiating therapy with kaletra: - the use of other active agents with kaletra is associated with a greater likelihood of treatment response [see clinical pharmacology (12.4) and clinical studies (14)] . - genotypic or phenotypic testing and/or treatment history should guide the use of kaletra [see clinical pharmacology (12.4)] . the number of baseline primary protease inhibitor mutations affects the virologic response to kaletra [see clinical pharmacology (12.4)] . - once daily administration of kaletra is not recommended for therapy-experienced adult patients or any pediatric patients. ● kaletra is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme) to any of its ingredients, including ritonavir. ●  co-administration of kaletra is contraindicated with drugs t

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - ranitidine hydrochloride -